Condition: Severe Mitral Valve Regurgitation, Severe Mitral Valve Stenosis · Sponsor: Shanghai HeartEpoch Medical Technology Co., Ltd
The study aims to evaluate the feasibility and safety of polymer artificial heart valve designed and developed by Shanghai HeartEpoch Medical technology Co. Ltd. for the treatment of the mitral valve diseases.
This description comes directly from the study's public registry record.
Jian Gang Wang · +8601064412431 · Jiangangwang@ccmu.edu.cn
Always discuss trial participation with your own doctor first.
| Beijing Anzhen Hospital | Beijing, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07243184